BCX9930, a Potent, Selective, Oral Factor D Inhibitor, Demonstrates Proof-of-Concept As Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
暂无分享,去创建一个
A. Risitano | W. Sheridan | M. Davidson | A. Kulasekararaj | Xilin Chen | A. Mcdonald | D. Gesty‐Palmer | M. Cornpropst | P. Collis | J. Malherbe | Kristin Tower